Shanghai Kinetic Medical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001FG9
CNY
7.22
0.13 (1.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
170.96
175.10
241.86
281.28
264.81
233.10
274.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
170.96
175.10
241.86
281.28
264.81
233.10
274.33
Raw Material Cost
62.77
78.40
121.30
149.09
143.16
116.75
161.77
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.02
0.30
2.32
2.97
1.89
2.17
1.95
Selling and Distribution Expenses
71.17
69.16
73.57
98.13
78.31
99.90
65.34
Other Expenses
1.17
1.00
1.14
0.87
0.93
-0.19
1.09
Total Expenditure (Excl Depreciation)
145.64
157.82
208.61
258.84
232.63
216.93
239.97
Operating Profit (PBDIT) excl Other Income
25.299999999999997
17.3
33.199999999999996
22.400000000000002
32.2
16.200000000000003
34.4
Other Income
51.03
24.98
11.28
0.12
4.41
3.28
10.69
Operating Profit (PBDIT)
74.53
37.38
55.15
34.13
55.65
-97.26
65.22
Interest
0.02
0.30
2.32
2.97
1.89
2.17
1.95
Exceptional Items
-2.84
49.16
0.55
8.12
-1.08
-73.51
0.03
Gross Profit (PBDT)
108.19
96.71
120.57
132.19
121.65
116.35
112.57
Depreciation
0.00
20.13
20.13
20.66
20.66
21.80
21.80
Profit Before Tax
71.67
66.11
33.26
18.62
32.01
-194.74
41.49
Tax
6.83
4.95
5.32
-0.61
4.20
-27.02
6.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
66.09
63.63
27.44
22.05
21.76
-161.63
25.83
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
66.09
63.63
27.44
22.05
21.76
-161.63
25.83
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.70
-3.61
-0.14
-3.68
4.16
-5.52
4.07
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
64.39
60.03
27.30
18.38
25.91
-167.15
29.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,916.15
2,863.10
2,786.68
2,766.69
2,748.06
2,720.92
2,864.27
Earnings per share (EPS)
0.09
0.09
0.04
0.03
0.03
-0.23
0.04
Diluted Earnings per share
0.09
0.09
0.04
0.03
0.03
-0.23
0.04
Operating Profit Margin (Excl OI)
13.74%
-4.42%
9.82%
4.75%
11.55%
-52.48%
11.93%
Gross Profit Margin
41.92%
49.25%
22.08%
13.97%
19.89%
-74.19%
23.07%
PAT Margin
38.66%
36.34%
11.35%
7.84%
8.22%
-69.34%
9.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.34% vs -27.61% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 7.33% vs 119.78% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 89.52% vs -71.75% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -100.00% vs -86.96% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Shanghai Kinetic Medical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
170.96
0
170.96
Other Operating Income
0.00
0.00
0.00
Total Operating income
170.96
0
170.96
Raw Material Cost
62.77
0
62.77
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.02
0
0.02
Selling and Distribution Expenses
71.17
0
71.17
Other Expenses
1.17
0.00
1.17
Total Expenditure (Excl Depreciation)
145.64
0
145.64
Operating Profit (PBDIT) excl Other Income
25.33
0.00
25.33
Other Income
51.03
0
51.03
Operating Profit (PBDIT)
74.53
0
74.53
Interest
0.02
0
0.02
Exceptional Items
-2.84
0
-2.84
Gross Profit (PBDT)
108.19
0
108.19
Depreciation
0.00
0
0.00
Profit Before Tax
71.67
0
71.67
Tax
6.83
0
6.83
Provisions and contingencies
0
0
0.00
Profit After Tax
66.09
0
66.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
66.09
0
66.09
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.70
0
-1.70
Other related items
0.00
0.00
0.00
Consolidated Net Profit
64.39
0
64.39
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,916.15
0
2,916.15
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
13.74%
0%
0.00
13.74%
Gross Profit Margin
41.92%
0%
0.00
41.92%
PAT Margin
38.66%
0%
0.00
38.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 17.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.34% vs -27.61% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -35.42% vs 7.55% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.44 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 7.33% vs 119.78% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 148.65% vs 56.02% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.35 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 89.52% vs -71.75% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -54.10% vs 30.28% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.74%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025